BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4562997)

  • 1. [Drug therapy of hemodynamic complications in acute myocardial infarct].
    Schröder R
    Internist (Berl); 1972 Sep; 13(9):380-7. PubMed ID: 4562997
    [No Abstract]   [Full Text] [Related]  

  • 2. [Standard therapy of acute myocardial infarction.--II: Management of arrhythmias].
    Rudolph W; Dirschinger J
    Herz; 1981 Feb; 6(1):14-24. PubMed ID: 6163689
    [No Abstract]   [Full Text] [Related]  

  • 3. [Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].
    Rudolph W; Dirschinger J
    Herz; 1981 Feb; 6(1):25-36. PubMed ID: 7216120
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy in cardiogenic shock.
    Ramdohr B
    Int J Clin Pharmacol; 1973 Apr; 7(2):118-26. PubMed ID: 4731279
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy.
    Takkunen J; Oilinki O; Huhti E; Vuopala U; Koivisto O
    Acta Med Scand; 1972 Sep; 192(3):165-70. PubMed ID: 5055261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic basis of acute myocardial infarct therapy].
    Bleifeld W; Hanrath P
    Dtsch Med Wochenschr; 1975 Jun; 100(24):1345-50. PubMed ID: 1132349
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiogenic shock and its current treatment.
    Willerson JT
    Tex Med; 1975 Apr; 71(4):49-59. PubMed ID: 1135757
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of hemodynamic monitoring in acute myocardial infarct].
    De Marchi M; De Bernardi A; Sclavo MG; Bevilacqua R; Piccinino C; Minelli M; Bottone W; Angelino PF
    Minerva Cardioangiol; 1981 Apr; 29(4):115-22. PubMed ID: 7242942
    [No Abstract]   [Full Text] [Related]  

  • 9. The failing myocardium. I. Drug management.
    Loeb HS; Rahimtoola SH; Gunnar RM
    Med Clin North Am; 1973 Jan; 57(1):167-85. PubMed ID: 4143986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic possibilities and therapy in the acute phase of myocardial infarct].
    Pachinger O
    Wien Med Wochenschr; 1984 Dec; 134(23-24):545-9. PubMed ID: 6442063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of ischemia associated with acute myocardial infarction].
    Forrester JS; Chaterjee K
    Coeur Med Interne; 1974; 13(1):11-20. PubMed ID: 4849467
    [No Abstract]   [Full Text] [Related]  

  • 12. [Digoxin and nitroglycerin in the treatment of heart failure in myocardial infarction].
    Lazutin VK; Broun DK; Zapevalov MV; Mikhaĭlov AA
    Sov Med; 1985; (8):3-8. PubMed ID: 3933127
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical therapy of cardiac insufficiency in the initial stage of myocardial infarct].
    Schweiser W
    Arch Mal Coeur Vaiss; 1973 Apr; 66(4):409-15. PubMed ID: 4198843
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phentolamine in the treatment of left heart failure in the acute stage of myocardial infarct. Hemodynamic study; preliminary results].
    Gardaz JP; Reynaert M; Grimbert F; Enrico JF; Perret C
    Schweiz Med Wochenschr; 1974 Nov; 104(44):1588-9. PubMed ID: 4422631
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basic principles of shock therapy].
    Schröder R
    Dtsch Med Wochenschr; 1971 Jan; 96(4):167-9. PubMed ID: 5539531
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple tachycardia forms occurring in a patient with Wolff-Parkinson-White syndrome and acute myocardial infarction.
    Ozaydín M; Varol E; Dogan A; Aslan SM; Altínbas A
    Minerva Cardioangiol; 2007 Jun; 55(3):427. PubMed ID: 17534262
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of brady- and tachycardia rhythm disorders].
    Klein W; Maurer E; Vrécko K
    Verh Dtsch Ges Inn Med; 1985; 91():200-12. PubMed ID: 4090618
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of cardiac dysrhythmias complicating acute myocardial infarction.
    Marriott HJ
    Geriatrics; 1968 Sep; 23(9):147-56. PubMed ID: 4970597
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial infarction: mortality factors in coronary care units.
    Dizadji H; Nissen R; Mathew M; Hoesley JB; Cernock WF
    Geriatrics; 1972 Dec; 27(12):76-86. PubMed ID: 4655490
    [No Abstract]   [Full Text] [Related]  

  • 20. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.